Literature DB >> 28300601

Functional Contacts between MPER and the Anti-HIV-1 Broadly Neutralizing Antibody 4E10 Extend into the Core of the Membrane.

Edurne Rujas1, Sara Insausti2, Miguel García-Porras2, Rubén Sánchez-Eugenia2, Kouhei Tsumoto3, José L Nieva4, Jose M M Caaveiro5.   

Abstract

The exceptional breadth of broadly neutralizing antibodies (bNAbs) against the membrane-proximal external region (MPER) of the transmembrane protein gp41 makes this class of antibodies an ideal model to design HIV vaccines. From a practical point of view, however, the preparation of vaccines eliciting bNAbs is still a major roadblock that limits their clinical application. Fresh mechanistic insights are necessary to develop more effective strategies. In particular, the function of the unusually long complementarity-determining region three of the heavy chain (CDRH3) of 4E10, an anti-MPER bNAb, is an open question that fascinates researchers in the field. Residues comprising the apex region are dispensable for engagement of the epitope in solution; still, their single mutation profoundly impairs the neutralization capabilities of the antibody. Since this region is very hydrophobic, it has been proposed that the apex is essential for anchoring the antibody to the viral membrane where MPER resides. Herein, we have critically examined this idea using structural, biophysical, biochemical, and cell-based approaches. Our results demonstrate that the apex region is not just a "greasy" spot merely increasing the affinity of the antibody for the membrane. We demonstrate the three-dimensional engagement of the apex region of the CDRH3 with the conglomerate of gp41 epitope and membrane lipids as a means of effective binding and neutralization of the virus. This mechanism of recognition suggests a standard route of antibody ontogeny. Therefore, we need to focus our efforts on recreating a more realistic MPER/lipid immunogen in order to generate more effective anti-HIV-1 vaccines.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  4E10 antibody; antigen–antibody binding; biomolecular recognition; complementarity-determining region; protein–membrane interaction; vaccine development

Mesh:

Substances:

Year:  2017        PMID: 28300601      PMCID: PMC5479317          DOI: 10.1016/j.jmb.2017.03.008

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  32 in total

1.  Reply to "The Broadly Neutralizing, Anti-HIV Antibody 4E10: an Open and Shut Case?".

Authors:  Edurne Rujas; Naveed Gulzar; Koldo Morante; Kouhei Tsumoto; Jamie K Scott; José L Nieva; Jose M M Caaveiro
Journal:  J Virol       Date:  2016-02-26       Impact factor: 5.103

Review 2.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

3.  Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10.

Authors:  Rosa M F Cardoso; Florence M Brunel; Sharon Ferguson; Michael Zwick; Dennis R Burton; Philip E Dawson; Ian A Wilson
Journal:  J Mol Biol       Date:  2006-11-10       Impact factor: 5.469

Review 4.  Benzophenone photophores in biochemistry.

Authors:  G Dormán; G D Prestwich
Journal:  Biochemistry       Date:  1994-05-17       Impact factor: 3.162

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies.

Authors:  James M Binley; Terri Wrin; Bette Korber; Michael B Zwick; Meng Wang; Colombe Chappey; Gabriela Stiegler; Renate Kunert; Susan Zolla-Pazner; Hermann Katinger; Christos J Petropoulos; Dennis R Burton
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 7.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

8.  Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.

Authors:  Gregory H Bird; Adriana Irimia; Gilad Ofek; Peter D Kwong; Ian A Wilson; Loren D Walensky
Journal:  Nat Struct Mol Biol       Date:  2014-11-24       Impact factor: 15.369

9.  Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface.

Authors:  Edurne Rujas; Jose M M Caaveiro; Angélica Partida-Hanon; Naveed Gulzar; Koldo Morante; Beatriz Apellániz; Miguel García-Porras; Marta Bruix; Kouhei Tsumoto; Jamie K Scott; M Ángeles Jiménez; José L Nieva
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  9 in total

1.  Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.

Authors:  Edurne Rujas; Daniel P Leaman; Sara Insausti; Lei Ortigosa-Pascual; Lei Zhang; Michael B Zwick; José L Nieva
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

2.  A Comprehensive Analysis of Anion-Quadrupole Interactions in Protein Structures.

Authors:  Suvobrata Chakravarty; Adron R Ung; Brian Moore; Jay Shore; Mona Alshamrani
Journal:  Biochemistry       Date:  2018-03-09       Impact factor: 3.162

3.  The Bilayer Collective Properties Govern the Interaction of an HIV-1 Antibody with the Viral Membrane.

Authors:  Pablo Carravilla; Leonardo Darré; Itziar R Oar-Arteta; Arturo G Vesga; Edurne Rujas; Gloria de Las Heras-Martínez; Carmen Domene; Jose L Nieva; Jose Requejo-Isidro
Journal:  Biophys J       Date:  2019-11-14       Impact factor: 4.033

4.  Structural Basis of Pan-Ebolavirus Neutralization by an Antibody Targeting the Glycoprotein Fusion Loop.

Authors:  Charles D Murin; Jessica F Bruhn; Zachary A Bornholdt; Jeffrey Copps; Robyn Stanfield; Andrew B Ward
Journal:  Cell Rep       Date:  2018-09-04       Impact factor: 9.423

5.  N-terminal Transmembrane-Helix Epitope Tag for X-ray Crystallography and Electron Microscopy of Small Membrane Proteins.

Authors:  Benjamin C McIlwain; Amanda L Erwin; Alexander R Davis; B Ben Koff; Louise Chang; Tatsiana Bylund; Gwo-Yu Chuang; Peter D Kwong; Melanie D Ohi; Yen-Ting Lai; Randy B Stockbridge
Journal:  J Mol Biol       Date:  2021-03-05       Impact factor: 6.151

6.  Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions.

Authors:  Pablo Carravilla; Jakub Chojnacki; Edurne Rujas; Sara Insausti; Eneko Largo; Dominic Waithe; Beatriz Apellaniz; Taylor Sicard; Jean-Philippe Julien; Christian Eggeling; José L Nieva
Journal:  Nat Commun       Date:  2019-01-08       Impact factor: 14.919

7.  Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.

Authors:  Charles Gotuaco Ang; Erik Carter; Ann Haftl; Shiyu Zhang; Adel A Rashad; Michele Kutzler; Cameron F Abrams; Irwin M Chaiken
Journal:  Microorganisms       Date:  2021-06-12

8.  Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry.

Authors:  Chen Yuan; Jia-Ye Wang; Hai-Jiao Zhao; Yan Li; Di Li; Hong Ling; Min Zhuang
Journal:  Retrovirology       Date:  2019-12-03       Impact factor: 4.602

9.  Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile.

Authors:  Edurne Rujas; Daniel P Leaman; Sara Insausti; Pablo Carravilla; Miguel García-Porras; Eneko Largo; Izaskun Morillo; Rubén Sánchez-Eugenia; Lei Zhang; Hong Cui; Ibon Iloro; Félix Elortza; Jean-Philippe Julien; Christian Eggeling; Michael B Zwick; Jose M M Caaveiro; José L Nieva
Journal:  iScience       Date:  2021-08-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.